Regulation of antiviral T cell responses by type I interferons.
about
The host immune response in respiratory virus infection: balancing virus clearance and immunopathology.Balancing Immune Protection and Immune Pathology by CD8(+) T-Cell Responses to Influenza InfectionThe Roles of RNase-L in Antimicrobial Immunity and the Cytoskeleton-Associated Innate ResponselncRNAs regulate the innate immune response to viral infectionIFN-γ Priming Effects on the Maintenance of Effector Memory CD4(+) T Cells and on Phagocyte Function: Evidences from Infectious DiseasesIdentification of Candidate Predictors of Lupus FlareExpansion of amphibian intronless interferons revises the paradigm for interferon evolution and functional diversityApproved Antiviral Drugs over the Past 50 YearsThe many faces of the flavivirus NS5 protein in antagonism of type I interferon signalingMultiple Roles for B-Lymphocytes in Sjogren's SyndromeTrial Watch-Oncolytic viruses and cancer therapyTrial Watch-Immunostimulation with cytokines in cancer therapyInhibition of Innate Immune Responses Is Key to Pathogenesis by ArenavirusesHarnessing the Power of Onco-Immunotherapy with Checkpoint InhibitorsIn Vivo and in Vitro Proteome Analysis of Human Immunodeficiency Virus (HIV)-1-infected, Human CD4+ T Cells.Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection.Expression of Myxovirus Resistance A (MxA) Is Associated with Tumor-Infiltrating Lymphocytes in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancers.Immunological dynamics associated with rapid virological response during the early phase of type I interferon therapy in patients with chronic hepatitis C.A Computational Model of Inhibition of HIV-1 by Interferon-AlphaUpdate on psoriasis immunopathogenesis and targeted immunotherapy.OASL1 deficiency promotes antiviral protection against genital herpes simplex virus type 2 infection by enhancing type I interferon productionMumps virus-induced innate immune responses in mouse Sertoli and Leydig cells.Membrane Perturbation-Associated Ca2+ Signaling and Incoming Genome Sensing Are Required for the Host Response to Low-Level Enveloped Virus Particle EntryType I interferons in viral control and immune regulationThe Type I Interferon-IRF7 Axis Mediates Transcriptional Expression of Usp25 Gene.Deletion of the type-1 interferon receptor in APPSWE/PS1ΔE9 mice preserves cognitive function and alters glial phenotypeCombination of TLR1/2 and TLR3 ligands enhances CD4(+) T cell longevity and antibody responses by modulating type I IFN production.Interferon alpha bioactivity critically depends on Scavenger receptor class B type I function.IDO1 and TGF-β Mediate Protective Effects of IFN-α in Antigen-Induced Arthritis.Modeling the dynamics of neonatal CD8+ T-cell responses.Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs.Integrating conventional and antibody-based targeted anticancer treatment into immunotherapyMouse Testicular Cell Type-Specific Antiviral Response against Mumps Virus ReplicationInterferon Lambda: Modulating Immunity in Infectious Diseases.Type I Interferons as Regulators of Lung Inflammation.Identification of an atypical etiological head and neck squamous carcinoma subtype featuring the CpG island methylator phenotypeInteractions between Type 1 Interferons and the Th17 Response in Tuberculosis: Lessons Learned from Autoimmune Diseases.Interferons and the Immunogenic Effects of Cancer Therapy.IFNA2: The prototypic human alpha interferon.Genetics of systemic sclerosis.
P2860
Q26766467-FEB485E4-431A-42E0-980D-EFFFC7F22599Q26767517-6E978031-AEAE-418B-8ED5-8B8ADB385FCBQ26772138-AFB0A22D-9E82-4583-ADB0-0D804A079F76Q26775906-0D08682F-84FD-4C7C-82A5-A7D63BB9C136Q26778206-1D93A060-9BD2-4D13-84BF-64807E882D4EQ26795372-1B8411F4-D06E-4B55-BEB3-17055429DC4BQ27469006-12365CAD-68FC-49DF-89D3-FD6C0D27D790Q27755387-2B2F7EC8-E653-4492-AA9C-A462072745E0Q27924714-82A5F5B1-D730-4CD7-8757-7FCC7F701086Q28068695-353EAED2-18EC-425D-874B-D9CB26785CAAQ28072347-09F5CBA7-582E-4AA8-BDEC-C2A81C318095Q28078725-A8C50D22-AE39-4B8E-B086-9FC5768A1127Q28079141-D4697BC4-E183-4CD7-8A74-487C58653601Q28086999-DF27F929-2DB6-41D5-BFD9-41B96C228B0FQ30398955-AF6283EC-323D-43E0-A8E2-B6912A79525FQ33425879-5346AD6D-67C8-4E0F-A857-04E7E0D6D450Q33584106-C28A0F7A-670F-4778-809C-DB1C4FC7AD80Q33797446-24297F56-41DB-4897-8629-38B63A24F9B2Q35969164-3E266D36-DCDD-43E8-B2FA-2A6006DC4088Q36445919-4DC10D47-6ACA-474F-A4C6-1C60BF2A7A58Q36448944-17B6442B-E29E-4CDF-A535-C8899700F740Q36499739-0941E981-50D2-40DA-8B4C-282289B7BE79Q36736620-0EB76C83-A5CD-4D42-A680-241CF1D8E6EDQ36767643-4D3613DE-37C4-42CB-9387-9C0946E3C9C6Q37065903-EF911B66-DBCF-4BB1-BA76-2A43F6C8C4ADQ37084675-6ABCDE94-00A5-4374-86C9-20E4DAA24031Q37223530-5E1E1426-D63E-4305-9A65-7C91AE8475CCQ37224572-E629F19B-583B-4EAE-8BD3-031C5702D4C3Q37321186-04BBC1BC-F905-4947-9E3F-96A5B8A1B42BQ37348167-B2A92128-ACB3-4E0D-B9E8-9A79781B5201Q37545050-7E778518-E3DF-4EA5-A8D4-16731EA7ACFDQ37592814-5CA66D9F-299A-420A-8EBF-712437285757Q37634675-37565BF8-999D-4AD9-AFA0-60E06DB64AE1Q37670446-869E3DE7-ED4B-4905-9B40-1E710E2AA717Q37691992-EFE5ABB5-AC16-4A74-9BC6-8637948A1D6DQ37714302-1F18C375-0507-40A5-A8C2-8D88227971C4Q37737549-8DA0A1A2-ABBE-4F67-B789-6EBF83BD0DC6Q38398206-657F779F-9538-470E-8A95-79D6219BFDABQ38486383-D6CA2565-BEF7-44DA-9D70-7DFDAB507F8EQ38511454-E914166E-B08A-4DCC-8CEC-82C19F57FCE5
P2860
Regulation of antiviral T cell responses by type I interferons.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Regulation of antiviral T cell responses by type I interferons.
@en
type
label
Regulation of antiviral T cell responses by type I interferons.
@en
prefLabel
Regulation of antiviral T cell responses by type I interferons.
@en
P356
P1476
Regulation of antiviral T cell responses by type I interferons.
@en
P2093
Josh Crouse
P304
P356
10.1038/NRI3806
P577
2015-03-20T00:00:00Z